Properties
Description
Mutant EGFR inhibitor is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells.
Molecular Formula
C27H30ClN7O2
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Mutant EGFR inhibitor can be used to explore its therapeutic effects on EGFR-mutated cancers.